Affluent Medical | WebDisclosure

PRESS RELEASE

published on 03/28/2024 at 17:45, 7 months 25 days ago

Affluent Medical announces coverage initiation of its stock by TP ICAP Midcap.
Affluent Medical announces coverage initiation of its stock by TP ICAP Midcap, with a target price of €3.20 and a potential upside of 87% according to the study 'Du baume au coeur'. The coverage adds to the financial analyst consensus

Affluent Medical Coverage Initiation TP ICAP Midcap Stock Clinical-phase MedTech
PRESS RELEASE

published on 03/28/2024 at 17:45, 7 months 25 days ago

Affluent Medical annonce l’initiation de couverture de son titre par TP ICAP Midcap.
Affluent Medical annonce l'initiation de couverture de son titre par TP ICAP Midcap, avec recommandation d'achat et objectif de cours de 3,20 €, représentant un potentiel de hausse de 87%

Affluent Medical MedTech TP ICAP Midcap Couverture De Titre Étude Financière
BRIEF

published on 03/12/2024 at 06:35, 8 months 10 days ago

Affluent Medical réussit la première implantation de son sphincter artificiel Artus

Affluent Medical MedTech Dispositif Médical Implantation Artus Incontinence Urinaire
BRIEF

published on 03/12/2024 at 06:35, 8 months 10 days ago

Affluent Medical successfully completes the first implantation of its Artus artificial sphincter

Medical Device Affluent Medical MedTech Artus Implementation Urinary Incontinence
PRESS RELEASE

published on 03/12/2024 at 06:30, 8 months 10 days ago

Affluent Medical annonce le succès de la première implantation chez l’homme de son sphincter artificiel Artus pour le traitement de l’incontinence urinaire d’effort.
Affluent Medical annonce le succès de la première implantation chez l'homme de son sphincter artificiel Artus pour le traitement de l'incontinence urinaire d'effort

Affluent Medical Dispositif Médical Incontinence Urinaire Artus Implantation
PRESS RELEASE

published on 03/12/2024 at 06:30, 8 months 10 days ago

Affluent Medical announces successful first-in-human implantation of its artificial sphincter Artus for the treatment of stress urinary incontinence.
Affluent Medical announces successful first-in-human implantation of its artificial sphincter Artus for the treatment of stress urinary incontinence in Prague, Czech Republic. The innovative medical device offers hope for the estimated 400 million patients affected worldwide

Medical Device Affluent Medical Urinary Incontinence Artus First-in-human Implantation
BRIEF

published on 02/29/2024 at 17:50, 8 months 22 days ago

Affluent Medical annonce des résultats positifs pour la valve Epygon

Affluent Medical Prothèses Médicales Valve Epygon Insuffisance Mitrale Biomimétique
BRIEF

published on 02/29/2024 at 17:50, 8 months 22 days ago

Affluent Medical Announces Positive Results for Epygon Valve

Affluent Medical Epygon Valve Mitral Regurgitation Biomimetics Medical Prostheses
BRIEF

published on 02/29/2024 at 17:50, 8 months 22 days ago

Affluent Medical Reports Promising Epygon Valve Performance and Recognition

Affluent Medical Cardiology Epygon Valve Mitral Regurgitation Minimally Invasive Surgery
BRIEF

published on 02/29/2024 at 17:50, 8 months 22 days ago

Des rapports médicaux riches promettent des performances et une reconnaissance de la valve Epygon

Cardiologie Insuffisance Mitrale Médical Aisé Vanne Épygone La Chirurgie Minimalement Invasive

Published on 11/22/2024 at 18:45, 3 hours 44 minutes ago

CORRECTING and REPLACING the Not-So-Secret Lives of REAL "Mormon" Wives - the Eye-Opening New Book From Cedar Fort Publishing & Media - is Now Available for Purchase, Just in Time for Christmas
Published on 11/22/2024 at 16:00, 6 hours 29 minutes ago

Manimal Tales Unveils Two New Personalized Christmas-Themed Books to Spread Holiday Magic and Joy!
Published on 11/22/2024 at 15:55, 6 hours 34 minutes ago

Independent Proxy Advisory Firm ISS Recommends Signal Gold Shareholders Vote for Arrangement Resolution and Private Placement Resolution
Published on 11/22/2024 at 15:15, 7 hours 14 minutes ago

Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment
Published on 11/22/2024 at 14:45, 7 hours 44 minutes ago

Jaguar Health Seeking Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in Dogs

View all ACCESSWIRE

Published on 11/22/2024 at 18:14, 4 hours 14 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 18:00, 4 hours 29 minutes ago

Holding(s) in Company
Published on 11/22/2024 at 17:53, 4 hours 36 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 5 hours 34 minutes ago

EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 6 hours 29 minutes ago

Proposed cancellation of admission to trading

View all EQS

Published on 11/22/2024 at 17:45, 4 hours 44 minutes ago

IMMERSION : RFA 2023/2024
Published on 11/22/2024 at 16:15, 6 hours 14 minutes ago

NRJ GROUP - Le Conseil d'Etat rejette le recours de NRJ 12 et NRJ GROUP
Published on 11/22/2024 at 14:35, 7 hours 54 minutes ago

Communiqué de presse Thales
Published on 11/22/2024 at 14:35, 7 hours 54 minutes ago

Thales Press release
Published on 11/21/2024 at 06:58, 1 day 15 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio

View all LES ECHOS COMFI WIRE

News